NL193820B - Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. - Google Patents

Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.

Info

Publication number
NL193820B
NL193820B NL9401005A NL9401005A NL193820B NL 193820 B NL193820 B NL 193820B NL 9401005 A NL9401005 A NL 9401005A NL 9401005 A NL9401005 A NL 9401005A NL 193820 B NL193820 B NL 193820B
Authority
NL
Netherlands
Prior art keywords
ibuprofen
dosage form
oral administration
pharmaceutical dosage
solid pharmaceutical
Prior art date
Application number
NL9401005A
Other languages
English (en)
Other versions
NL9401005A (nl
NL193820C (nl
Inventor
Federico Stroppolo
Daniele Bonadeo
Gian Franco Fornasini
Annibale Gazziniga
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Publication of NL9401005A publication Critical patent/NL9401005A/nl
Publication of NL193820B publication Critical patent/NL193820B/nl
Application granted granted Critical
Publication of NL193820C publication Critical patent/NL193820C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NL9401005A 1993-06-21 1994-06-20 Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen. NL193820C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001325A IT1264856B1 (it) 1993-06-21 1993-06-21 Composizione farmaceutica ad attivita' analgesica
ITMI931325 1993-06-21

Publications (3)

Publication Number Publication Date
NL9401005A NL9401005A (nl) 1995-01-16
NL193820B true NL193820B (nl) 2000-08-01
NL193820C NL193820C (nl) 2000-12-04

Family

ID=11366436

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9401005A NL193820C (nl) 1993-06-21 1994-06-20 Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.

Country Status (15)

Country Link
US (2) US5500226A (nl)
JP (1) JPH07101855A (nl)
BE (1) BE1007194A3 (nl)
CA (1) CA2125643C (nl)
CH (1) CH687850A5 (nl)
DE (1) DE4420856A1 (nl)
DK (1) DK174687B1 (nl)
ES (1) ES2099021B1 (nl)
FR (1) FR2706892B1 (nl)
GB (1) GB2279250B (nl)
HU (1) HU211669A9 (nl)
IT (1) IT1264856B1 (nl)
NL (1) NL193820C (nl)
NO (1) NO310443B1 (nl)
SE (1) SE9402157L (nl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica
US5654334A (en) * 1995-06-23 1997-08-05 Oklahoma Medical Research Foundation Analgesic use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester
US5707967A (en) * 1995-10-27 1998-01-13 Vanmoor; Arthur Pain relief compositions
US6177467B1 (en) 1996-09-26 2001-01-23 Oklahoma Medical Research Foundation Use of N-L-α-aspartyl-L-phenylalanine 1-methyl ester and its derivatives in disease regression
AU3221599A (en) 1998-04-03 1999-10-25 Daily Wellness Company, The Compositions comprising l-arginine, ginseng and gingko biloba for enhancing blood circulation
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
KR100523242B1 (ko) * 2000-05-18 2005-10-24 한미약품 주식회사 이부프로펜을 함유하는 정제 조성물
US20020192161A1 (en) * 2001-04-10 2002-12-19 Fahkreddin Jamali Animal model for evaluating analgesics
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
KR100678837B1 (ko) * 2005-01-03 2007-02-05 한미약품 주식회사 활성 성분으로 덱시부프로펜을 함유하는 시럽제 조성물 및그의 제조 방법
KR100730393B1 (ko) 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
MX2010004974A (es) * 2010-05-04 2011-11-23 Senosiain S A De C V Lab Combinacion de un aine y un aminoacido.
KR101890649B1 (ko) * 2013-07-30 2018-09-28 라이온 가부시키가이샤 정제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
ATE50493T1 (de) * 1986-11-14 1990-03-15 Puetter Medice Chem Pharm Ibuprofen enthaltendes arzneimittel.
US4851444A (en) * 1987-07-10 1989-07-25 Analgesic Associates Onset-hastened/enhanced analgesia
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
ATE128452T1 (de) * 1989-10-17 1995-10-15 Merck & Co Inc S(+)-ibuprofen-l-aminosäure und s(+)-ibuprofen-d- aminosäure als analgetika mit grösserem pharmakologischem potential.
IT1264856B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizione farmaceutica ad attivita' analgesica

Also Published As

Publication number Publication date
GB2279250B (en) 1998-02-25
NL9401005A (nl) 1995-01-16
JPH07101855A (ja) 1995-04-18
CA2125643A1 (en) 1994-12-22
DE4420856A1 (de) 1994-12-22
US5645857A (en) 1997-07-08
NO942343D0 (nl) 1994-06-20
NO310443B1 (no) 2001-07-09
SE9402157D0 (sv) 1994-06-20
ES2099021A1 (es) 1997-05-01
CH687850A5 (it) 1997-03-14
IT1264856B1 (it) 1996-10-17
BE1007194A3 (fr) 1995-04-18
SE9402157L (sv) 1994-12-22
DK72594A (da) 1994-12-22
FR2706892B1 (nl) 1995-10-20
US5500226A (en) 1996-03-19
NO942343L (no) 1994-12-22
NL193820C (nl) 2000-12-04
HU211669A9 (en) 1995-12-28
ITMI931325A0 (it) 1993-06-21
ITMI931325A1 (it) 1994-12-21
CA2125643C (en) 2007-09-04
GB9410898D0 (en) 1994-07-20
GB2279250A (en) 1995-01-04
FR2706892A1 (nl) 1994-12-30
ES2099021B1 (es) 1998-01-16
DK174687B1 (da) 2003-09-15

Similar Documents

Publication Publication Date Title
DZ1876A1 (fr) Médicaments pour administration orale.
BR9607862A (pt) Composição farmacêutica filmogênica para administração transdérmica
FR2683146B1 (fr) Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse.
ATE219377T1 (de) Neue galenische orale pharmazeutische formulierung
ATE312602T1 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
NO961136D0 (no) Farmasöytisk formuleringsgrunnlag for nano-suspensjoner
EE200000395A (et) Peroraalne farmatseutiline pulseeriva vabanemisega annusvorm
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
KR970006279A (ko) 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
FI954767A (fi) Lipofiilisiä lääkeaineita sisältävä farmaseuttinen koostumus
NL193820B (nl) Vaste farmaceutische doseringsvorm voor orale toediening van Ibuprofen.
DK0956010T3 (da) Farmaceutiske mikrosfærer indeholdende valproinsyre til oral administrering
DZ1559A1 (fr) Compositions pharmaceutiques.
PT835103E (pt) Nanoparticulas para administracao oral de agentes farmaceuticos de baixa solubilidade
IT9019112A1 (it) Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
DZ1926A1 (fr) Formulations pharmaceutiques.
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
BR9607433A (pt) Composição farmacêutica para administração parental
FI952377A0 (fi) Farmaseuttisia ibuprofeenikoostumuksia
IT8421874A0 (it) Forma farmaceutica solida orale ad azione sequenziale per la somministrazione di farmaci ad effetto collaterale ulcerogeno.
IT9021021A0 (it) Composizioni farmaceutiche per la somministrazione orale di irudina
NO980384D0 (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
DE19681529D2 (de) Pharmazeutische Darreichungsform
ITMI992736A0 (it) Composizioni farmaceutiche per la somministrazione localizzata nel cav o orale di farmaci antiinfiammatori non stereoidei utili per la terapi
FI973277A0 (fi) Farmaseuttisia valmisteita TNF:n estämiseksi

Legal Events

Date Code Title Description
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20140620